Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery

Journal of Liposome Research

Volumn 22, Issue 4, 2012, Pages 285-294

  Bobbala, Sharan Kumar Reddy ^a   Veerareddy, Prabhakar Reddy ^b  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^b Chaitanya College of Pharmacy Education and Research   (India)

Author keywords

Bioavailability; Dissolution; Flux; Liposomes; Permeability

Indexed keywords

ISRADIPINE; LIPOSOME;

AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SCREENING; EX VIVO STUDY; INFRARED SPECTROSCOPY; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TIME TO MAXIMUM PLASMA CONCENTRATION; WISTAR RAT; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; HUMANS; ISRADIPINE; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, SCANNING; POWDER DIFFRACTION; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84870279759     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.697067     Document Type: Article

References (36)

1. Ahn, B. N., Kim, S. K., Shim, C. K. (1995). Proliposomes as an intranasal dosage form for the sustained delivery of propranolol. J Control Release 34:203-120.
2. Al-Meshal, A. M. (1998). Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. Int J Pharm 168:163-168.
3. Arien, A., Dupuy, B. (1997). Encapsulation of calcitonin in liposomes depends in the vesicle preparation method. J Microencapsul 14:753-760. (Pubitemid 27483093)
4. Bernsdorf, C., Wolf, A., Winter, R., Gratton, E. (1997). Efect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys J 72:1264-1277. (Pubitemid 27113649)
5. Betageri, G. V. (2005). Proliposomal drug delivery system. US Patent:6, 849, 269.
6. Carr, R. L. (1965). Evaluation fow properties of solids. Chem Eng 72:163-168.
7. Chandra, A., Sharma, P. K. (2008). Proniosome based drug delivery system of piroxicam. Afr J Pharm Pharmacol 9:184-190.
8. Chaudhari, K. B., Labhasetwar, V., Dorle, A. K. (1994). Liposomes as a carrier for oral administration of insulin: efect of formulation factors. J Microencapsul 11:319-325. (Pubitemid 24148441)
9. Christensen, H. R., Antonsen, K., Simonsen, K., Lindekaer, A., Bonde, J., Angelo, H. R., et al. (2000). Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected. Pharmacol Toxicol 86:178-182. (Pubitemid 30205186)
10. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., Houin, G. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 278:119-131. (Pubitemid 38670443)
11. Deshmukh, D. D., Ravis, W. R., Betageri, G. V. (2008). Improved delivery of cromolyn from oral proliposomal beads. Int J Pharm 358:128-136.
12. Fitton, A., Benfeld, P. (1990). Isradipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 40:31-74.
13. Garbuzenko, O., Barenholz, Y., Priev, A. (2005). Efect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids 135:117-129. (Pubitemid 40744733)
14. Gopinath, D., Ravi, D., Rao, B. R., Apte, S. S., Renuka, D., Rambhau, D. (2004). Ascorbyl palmitate vesicles (Aspasomes): formation, characterization, and applications. Int J Pharm 271:95-113. (Pubitemid 38210088)
15. Gregoriadis, G. (1993). Liposome technology, 2nd ed. Boca Raton, Florida, USA: CRC Press.
16. Hiremath, P. S., Soppimath, K. S., Betageri, G. V. (2009). Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2, and rat intestine. Int J Pharm 380:96-104.
17. Kim, W. C., Oh, S. H., Kim, S. H., Kim, O. J., Lee, M. S. (2007). Parkinsonism and related disorders (pp. 113-140). Amsterdam: Elsevier Science Amsterdam B V.
18. Leroueil-Le Verger, M., Fluckiger, L., Kim, Y. I., Hofman, M., Maincent, P. (1998). Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46:137-143. (Pubitemid 28414471)
19. Malaterre, V., Ogorka, J., Loggia, N., Gurny, R. (2009). Approach to design push-pull osmotic pumps. Int J Pharm 376:56-62.
20. Nagarsenker, M. S., Londhe, V. Y., Nagkarn, G. D. (1999). Preparation and evaluation of liposomal formulation of tropicamide for ocular delivery. Int J Pharm 190:63-71. (Pubitemid 29467473)
21. Ogiso, T., Niinaka, N., Iwaki, M. (1996). Mechanism for enhancement efect of lipid disperse system on percutaneous absorption. J Pharm Sci 85:57-64. (Pubitemid 26029626)
22. Payne, N. I., Timmis, P., Ambrose, C. V., Warel, M. D. (1986). Proliposomes: a novel solution to an old problem. J Pharm Sci 75:325-329. (Pubitemid 16137097)
23. Plessis, J., Ramachandran, C., Weiner, N., Miller, D. G. (1991). Te infuence of particle size of liposomes on deposition of drug into skin. Int J Pharm 103:277-282.
24. Potluri, P., Betageri, G. V. (2006). Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone. Drug Deliv 13:227-232.
25. Pradip, K. G., Rita, J. M., Manish, L. U., Rayasa, S. R. M. (2006). Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 7:E1-E5.
26. Prisant, L. M., Elliott, W. J. (2003). Drug delivery systems for treatment of systemic hypertension. Clin Pharmacokinet 42:931-943.
27. Rajesh, K., Gupta, R. B., Betageri, G. V. (2001). Formulation, characterization, and in vitro release of glyburide from proliposomal beads. Drug Deliv 8:25-27. (Pubitemid 32179160)
28. Sammour, O. A., Hammad, M. A., Megrab, N. A., Zidan, A. S. (2006). Formulation and optimization of mouth dissolving tablets containing rofecoxib solid dispersion. AAPS Pharmscitech 7:1-8.
29. Song, K. H., Chung, S. J., Shim, C. K. (2002). Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release 84:7-37.
30. Staniforth, J. N. (1988). Te science dosage form design. In: Aulton, M. E. (Ed.), Pharmaceutics (pp. 610-636). Edinburgh: Churchill Livingstone, Longman Group.
31. Staniforth J. N. (2002). Powder fow. Te science of dosage form design. In: M. Aulton, M. E. (Ed.), Pharmaceutics (pp. 197-210). Edinburgh: Churchill Livingstone, Longman Group.
32. Subheet, J., Parijat, J., Umamaheshwari, R. B., Jain, N. K. (2003). Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013-1026. (Pubitemid 37346103)
33. Touitou, E., Junginger, H. E., Weiner, N. D., Nagai, T., Mezei, M. (1994). Liposomes as carrier for topical and transdermal delivery. J Pharm Sci 83:1189-1203. (Pubitemid 24282318)
34. Tran, T. T., Tran, P. H., Choi, H. G., Han, H. K., Lee, B. J. (2010). Te roles of acidifers in solid dispersions and physical mixtures. Int J Pharm 384:60-66.
35. Valleri, M., Mura, P., Maeshrelli, F., Cirri, M., Ballerini, R. (2004). Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm 30:525-534. (Pubitemid 38821864)
36. Yan-yu, X., Yun-mei, S., Zhi-peng, C., Qi-peng, P. (2006). Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 319:162-168.